Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

​ Conditions: Non-Small Cell Lung Cancer; Non-squamous Non-Small Cell Lung Cance

Interventions: Drug: Plinabulin; Drug: Docetaxel; Drug: Placebo (matching plinabulin placebo)

Sponsors: BeyondSpring Pharmaceuticals Inc.

Not yet recruiting Conditions: Non-Small Cell Lung Cancer; Non-squamous Non-Small Cell Lung Cance
Interventions: Drug: Plinabulin; Drug: Docetaxel; Drug: Placebo (matching plinabulin placebo)
Sponsors: BeyondSpring Pharmaceuticals Inc.
Not yet recruiting